Immunotherapy or antiangiogenic therapy plus chemotherapy as first‐line treatment of patients with PD‐L1(‐) advanced non‐squamous non‐small cell lung cancer in a Chinese cohort

enthalten in: Cancer Medicine | 2023

von Xia, R. | Li, Y. | Yang, L. | +1

The impact of antibiotic selection and interval time among advanced non‐small cell lung cancer patients receiving prior antibacterial treatment and first‐line chemotherapy

enthalten in: Cancer Medicine | 2022

von Tian, X. | Mei, T. | Yu, M. | +3

Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung‐molGPA) in a Chinese cohort : A retrospective study of multiple institutions

enthalten in: Cancer Medicine | 2020

von Zhang, T. | Zhang, Y. | Zhou, L. | +21